Legislative, Regulatory & Legal

In the wake of the cancellation of its RxIMPACT Day on Capitol Hill due to the coronavirus, NACDS is urging members to use its virtual fly-in resource.

NACDS lauded the collaborative work that led to the enactment of House Bill 42 that improves access to health care for citizens of New Mexico.

A new bill introduced by Sens. Bill Cassidy, R-La., and Dick Durbin, D-Ill., focused on improving transparency around third-party sellers online, is getting the backing of Walgreens.

Zydus Cadila has received the FDA's nod for generic Truvada 200 mg/300 mg, and tentative approval for additional dosage strengths.

In the wake of the COVID-19 outbreak, NACDS is canceling its RxIMPACT Day on Capitol Hill and holding its policy council meeting by phone.

As part of a resolution with the U.S. Department of Justice Antitrust Division, Sandoz has agreed to pay $195 million.

In the wake of the coronavirus spreading, the Association for Accessible Medicines said it will work to help ensure that patients in the United States get access to generic and biosimilar medicines.

NACDS has filed a brief supporting an Arkansas law at question in an upcoming Supreme Court case, and several pharmacy groups including NCPA, APA, APhA and NASPA have filed a separate brief also in support of the law.